KOAH\'lı hastalarda egzersiz kapasitesi ve dinamik hiperinflasyonun değerlendirilmesi

Amaç: Bu çalışmanın amacı KOAH\'lı ve sağlıklı olgularda egzersize yanıt olarak dinamik hiperinflasyondaki değişiklikleri araştırmaktır. Yöntemler: Bu çalışmada, istirahat spirometrik ölçümlerinde kronik obstrüktif akciğer hastalığı (KOAH) olan hastalar ile sağlıklı bireylerin egzersiz kapasiteleri karşılaştırıldı. Stabil KOAH\'lı olgularla sağlıklı olgular, egzersiz kapasiteleri ve dinamik hiperinflasyon açısından karşılaştırıldı. Bulgular: Çalışmaya 19 KOAH\'lı ve 13 sağlıklı birey alındı. KOAH\'lı grupta egzersizde hiperinflasyon parametrelerindeki değişiklikleri gösterebilmek amacıyla istirahatte ve maksimum egzersizde inspiratuar kapasite (IC) ve end-ekspiratuar akciğer volümleri (EELV) ölçüldü. KOAH\'lı olgular ile kontrol grubu arasında maksimum dakika ventilasyonu, maksimum oksijen tüketimi ve solunum paterni, solunum rezervi, egzersiz süresi yönünden anlamlı farklılık vardı (p

Evaluation of dynamic hyperinflation and exercise capacity in patients with COPD

Objective: The aim of this study was to investigate changes in dynamic hyperinflation in response to exercise in patients with COPD and healthy individuals. Methods: In this study, resting in the spirometric measurements, exercise capacity of patients with chronic obstructive pulmonary diseases (COPD) compared with healthy individuals. Exercise capacity of COPD patients and healthy controls were performed and were compared in terms of dynamic hyperinflation. Results: Patients with stable COPD (n=19) and healthy controls (n=13) were included. Subjects performed pulmonary function tests and an incremental exercise test on cycle ergometry (Inspiratory capacity (IC), end expiratory lung volume (EELV)). Statistically significant differences (p

___

  • O’Donnell DE. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. In: Weissman IM, Zeballos RJ (eds). Cardiovascular and Respiratory System Responses and Limitations to Exercise.Clinical Exercise Testing. Basel: Karger AG, 2002:138-158.
  • O’Donnell DE, Voduc N. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004;24:86-94.
  • Demir T, İkitimur HD. Dinamik hiperinflasyon. Umut S. (editör). Akciğer Fonksiyon Testleri Fizyolojiden Klinik Uygulamaya. İstanbul: 2004:66-71.
  • O’Donnell DE, Revill S, Webb K. Dynamic hyperinfla- tion and exercise intolerance in COPD. Am J Respir Crit Care Med 2001;164:770-777.
  • Ulubay G, Görek A, Savaş Ş ve ark. KOAH’lı olgular- da kardiyopulmoner egzersiz testi ile egzersiz kapa- sitesi ve dinamik hiperinflasyonun değerlendirilmesi. Tüberküloz ve Toraks Dergisi 2005;53:340-346.
  • Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chron- ic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:532-555.
  • Quanjer P, Tammeling FJ, Cotes JE, et al. Standardised lung function testing; lung volumes and forced ventila- tory flows. Eur Respir J 1993;6:5-40.
  • Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation. 3rd ed. Baltimore: A Wolters Kluwer Comp, 1999:10-56.
  • O’Donnell DE, Miu LAM. Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1557-1565.
  • Dolmage TE, Goldstein RS. Repeatability of inspira- tory capacity during incremental exercise in patients with severe COPD. Chest 2002;121:708-714.
  • Jones NL, Makrides L, Hitchcock C, et al. Normal standards for an incremental progressive cycle er- gometer test. Am Rev Respir Dis 1985;131:700-708.
  • Pineda H, Haas F, Axen K, et al. Accuracy of pulmo- nary function tests in predicting exercise tolerance in chronic obstructive pulmonary disease. Chest 1984;86:564-567.
  • Covey MK, Larson JL, Alex CG, et al. Test-retest re- liability of symptom-limited cycle ergometer tests in patients with chronic obstructive pulmonary disease. Nurs Res 1999;48:9-19.
  • Gallagher CG. Exercise limitation and clinical exer- cise testing in chronic obstructive pulmonary disease. Clin Chest Med 1994;305-327.
  • Diaz O, Villafranca C. Breathing pattern and gas exchange at gas exchange in COPD patients with and without tidal flow limitation at rest. Eur Respir J 2001;17:1120-1127.
  • Akkoca Ö, Ferda Ö, Saryal S, ve ark. Hafif ve orta şiddetteki kronik obstrüktif akciğer hastalıklarında eg- zersiz kapasitesi. Tüberküloz ve Toraks 2001;49:5-12.
  • Gelb AF, Gutierrez CA. Simplified detection of dynam- ic hyperinflation. Chest 2004;126:1860-1885.
  • Martin JM, Carrizo SJ. Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise perfor- mance during the 6-minute- walk test in chronic ob- structive pulmonary disease. Am J Respir Crit Care Med 2001;163:1395-1399.
  • O’Donnell DE, Fluge T. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832-840.
  • O’Donnell DE, Lam M, Webb KA. Spirometric corre- lates of improvement in exercise performance after anticholinergic therapy in COPD. Am J Respir Crit Care Med 1999;160:542-549.